Picture of Oncozenge AB logo

ONCOZ Oncozenge AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Oncozenge AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PRESSARSARSARSPRESS
Standards:
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.89-43.6-15.9-8.69-15.8
Non-Cash Items023.50-0.003-0.153
Other Non-Cash Items
Changes in Working Capital0.127-1.97-1.18-0.0762.88
Change in Accounts Receivable
Change in Other Liabilities
Cash from Operating Activities-4.77-22.1-17.1-8.76-13.1
Other Investing Cash Flow Items-5.3600.570
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-5.3600.570
Financing Cash Flow Items-8.740-0.635
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities51.3012.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash41.2-22.1-16.5-8.76-0.149